Biotechnology
Avance Clinical Launches Dedicated Center Of Excellence To Accelerate Early Phase Biotech Trials
Share
Avance Clinical Launches Dedicated Center of Excellence
ADELAIDE, Australia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, the Australia-based global CRO partner for biotechs, has been a leader in early phase clinical research for more than 30 years. With operations across Australia, New Zealand, North America, Asia, and Europe, the company delivers biotech sponsors both deep local expertise and global reach. Expanding on this legacy, Avance Clinical today announced the launch of its dedicated Early Phase Center of Excellence for Biotechs, designed to deliver scientific rigor, innovative trial design, global regulatory insight, and operational excellence for smarter, more efficient early phase trials with significant cost savings for global biotechs.
The Center of Excellence solves the challenges facing early phase biotechs, including approval delays, slow site activation, and inefficient trial designs that drive up costs and compromise data quality. As a dedicated biotech accelerator, the center designs strategic and scalable programs that move seamlessly from pre-clinical through Phase I, into global expansion, and deliver expedited data insights. Services range from:
- Assessing molecule suitability for healthy volunteers
- Advising on IND-enabling pre-clinical studies
- Designing and delivering, science-driven, adaptive clinical trial protocols that rapidly inform Phase II development
The center’s flagship ClinicReady program launches studies rapidly in Australia with no IND requirements accelerating access to cost effective, high-quality clinical data.
“Early phase biotechs face challenges in bringing innovative molecules to market, and our Early Phase Center of Excellence for Biotechs is designed to tackle these very pain points,” said Liahna Toy, VP of Commercial Business Development. “We’re not just providing services; we consistently anticipate our partners’ needs by helping them navigate regulatory challenges, optimize study designs, and accelerate timelines while preserving scientific standards.”
The center leverages Avance Clinical’s scientific leads and operational experts, who guide clinical protocol development, biomarker strategy, ethics submissions, efficient trial delivery, and accelerated data access. The company’s proven Phase I unit partners and extensive site and vendor networks ensure studies launch successfully and deliver globally accepted data rapidly.
“By combining our deep scientific and regulatory knowledge, early phase operational excellence, and strategic planning capabilities, we’re providing our biotech clients with the expertise they need to significantly accelerate their early phase clinical programs,” said Ben Edwards, Chief Operating Officer. “This is not just about conducting trials; this is about accelerating biotech clinical program delivery and the rapid advancement of new treatments for patients who need them.”
About Avance Clinical
Avance Clinical is the largest premium full-service Australian headquartered CRO delivering high-quality clinical trials in Australia, New Zealand, Asia, North America, and Europe for international biotechs. The company has won multiple Frost & Sullivan CRO Market Leadership and Customer Value Leadership Awards. With over 30 years of experience and deep expertise across more than 250 indications, Avance Clinical provides services from pre-clinical to late-phase trials, supported by best-in-class regulatory, clinical, and operational expertise.
Find out more:
- Visit our website to find out more or request a proposal www.avancecro.com
- Discover the Australian Advantage
- Book a Meeting with our expert team
- Meet Avance Clinical at upcoming conferences
CONTACT:
Gabe Martinez
Director Content, Media, & PR
308-237-5567
Pr@scorrmarketing.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/d04e25d6-9053-4ca3-acbd-651b5fbf91e1
Frequently Asked Questions
What is Avance Clinical's Early Phase Center of Excellence?
It's a dedicated unit designed to accelerate early-stage biotech trials by providing scientific rigor, innovative trial design, regulatory insight, and operational excellence.
What services does the center offer?
The center provides services ranging from molecule suitability assessment and IND-enabling studies to designing and delivering science-driven, adaptive clinical trial protocols.
How does the ClinicReady program accelerate studies?
It allows rapid study launches in Australia without IND requirements, accelerating access to cost-effective, high-quality clinical data.
First published on Wed, Oct 22, 2025
Liked what you read? That’s only the tip of the tech iceberg!
Explore our vast collection of tech articles including introductory guides, product reviews, trends and more, stay up to date with the latest news, relish thought-provoking interviews and the hottest AI blogs, and tickle your funny bone with hilarious tech memes!
Plus, get access to branded insights from industry-leading global brands through informative white papers, engaging case studies, in-depth reports, enlightening videos and exciting events and webinars.
Dive into TechDogs' treasure trove today and Know Your World of technology like never before!
Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.
Trending GlobeNewswire
Auditoria Named In Top 50 Financial Technology Companies By The Financial Technology Report
GS1 Brings Trusted Medical Product Information To Smartphones Through Collaboration With Google
Cyber Security Teams Harness Automation And AI To Drive Productivity Gains
Picus Security Recognized As Customers Choice In Gartner VOC Report On Adversarial Exposure Validation
Qued Launches ROI Calculator To Show Real Savings From Automated Scheduling
Join Our Newsletter
Get weekly news, engaging articles, and career tips-all free!
By subscribing to our newsletter, you're cool with our terms and conditions and agree to our Privacy Policy.
Join The Discussion